Literature DB >> 31436227

Interpretation of adverse reactions and complications in Chinese expert consensus of Iodine-125 brachytherapy for pancreatic cancer.

Qingchun Li1, Yun Liang2, Ye Zhao1, Baodong Gai1.   

Abstract

Owing to the location of the pancreas and its complex anatomical relationship, it is difficult to perform radioactive Iodine-125 seed implantation in patients with pancreatic cancer as it can cause surgical side effects and further complications. To standardize the procedure of radioactive Iodine-125 seed implantation in the treatment of pancreatic cancer and reduce the occurrence of adverse reactions and complications during and after operation, the Chinese Medical Doctor Association of Radioactive Seed Implantation Technology Expert Committee, Committee of Minimally Invasive Therapy in Oncology, Chinese Anti-Cancer Association, and the Radioactive Seed Therapy Branch organized and helped establish an expert consensus in China regarding radioactive Iodine-125 seed implantation in the treatment of pancreatic cancer. This article aims at interpreting the adverse reactions and complications after the implantation of radioactive seeds.

Entities:  

Keywords:  Adverse reactions; complications; consensus; pancreatic cancer; radioactive particles

Mesh:

Substances:

Year:  2019        PMID: 31436227     DOI: 10.4103/jcrt.JCRT_884_18

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  2 in total

1.  Investigation of a novel brachytherapy ureteral stent: trial studies on normal beagle dogs.

Authors:  Dechao Jiao; Yuan Yao; Kaihao Xu; Qinyu Lei; Zongming Li; Xinwei Han; Jianzhuang Ren
Journal:  J Cancer Res Clin Oncol       Date:  2021-01-25       Impact factor: 4.553

2.  Analysis of Cells Proliferation and MicroRNAs Expression Profile in Human Chondrosarcoma SW1353 Cells Exposed to Iodine-125 Seeds Irradiation.

Authors:  Fusheng Li; Jia Xu; Yue Zhu; Liang Sun; Renyi Zhou
Journal:  Dose Response       Date:  2020-04-23       Impact factor: 2.658

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.